It has been recently demonstrated that the expression of CD133 is associated with markers of hypoxia and/or tumor microvasculature in human breast tumors [12,28] and, in TNBC, CD133(+) cells with cancer stem cell characteristics associate with vasculogenic mimicry [29]. This evidence concerns the gene PROM1 and breast neoplasm.